Are there any known interactions or contraindications between methylphenidate and qualitative or functional platelet defects?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18430087
Cited by: 0

Abstract

The evidence is limited regarding interactions between methylphenidate and platelet defects, mainly highlighting thrombocytopenia cases rather than qualitative or functional platelet abnormalities.

Fields of Study & Subjects

Platelet Disorders and Treatments Antiplatelet Therapy and Cardiovascular Diseases Pharmacovigilance and Adverse Drug Reactions

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
30 January 2026